ZORZON, MARINO
 Distribuzione geografica
Continente #
NA - Nord America 5.535
EU - Europa 2.330
AS - Asia 890
SA - Sud America 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 8.776
Nazione #
US - Stati Uniti d'America 5.524
UA - Ucraina 778
IT - Italia 472
CN - Cina 323
SE - Svezia 301
FI - Finlandia 243
TR - Turchia 218
HK - Hong Kong 212
GB - Regno Unito 139
IE - Irlanda 115
BG - Bulgaria 114
SG - Singapore 108
FR - Francia 94
DE - Germania 32
BE - Belgio 21
IN - India 15
CA - Canada 11
IR - Iran 9
BR - Brasile 7
CH - Svizzera 7
NL - Olanda 6
AU - Australia 4
AT - Austria 2
EU - Europa 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
KR - Corea 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 8.776
Città #
Fairfield 748
Jacksonville 673
Woodbridge 640
Wilmington 417
Houston 409
Ann Arbor 401
Ashburn 392
Chandler 341
Seattle 297
Cambridge 272
Princeton 228
Izmir 214
Hong Kong 212
Beijing 150
Sofia 114
Dublin 113
Milan 76
Singapore 62
San Diego 49
Verona 48
Boardman 37
Dearborn 34
Buffalo 26
Bremen 23
Norwalk 23
Brussels 21
Chicago 21
Trieste 21
Washington 17
Helsinki 16
Venezia 16
Auburn Hills 10
Phoenix 10
Nanjing 9
Hefei 8
Rome 8
Toronto 8
Kunming 7
San Mateo 6
Augusta 5
Guangzhou 5
Leawood 5
Zhengzhou 5
Des Moines 4
Jinan 4
Monmouth Junction 4
Redwood City 4
Avellino 3
Bern 3
Birmingham 3
Falls Church 3
Gallarate 3
Hebei 3
Kocaeli 3
Los Angeles 3
Mountain View 3
Mumbai 3
Pordenone 3
Redmond 3
Shenyang 3
Baotou 2
Chiari 2
Chongqing 2
Dakar 2
Dallas 2
Francavilla Al Mare 2
Fuzhou 2
Gurgaon 2
Hangzhou 2
Liebefeld 2
London 2
Mestre 2
Mirano 2
Munich 2
Niterói 2
Prignano Cilento 2
Sollentuna 2
Sydney 2
Trani 2
Udine 2
Vienna 2
Zurich 2
Albinea 1
Ambato 1
Amsterdam 1
Ardabil 1
Arzano 1
Ascoli Piceno 1
Auckland 1
Bari 1
Buti 1
Canzo 1
Carlentini 1
Caserta 1
Costa Mesa 1
Dhaka 1
Dingle 1
Düsseldorf 1
Ferrara 1
Forest City 1
Totale 6.314
Nome #
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis. 209
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue. 167
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls. 167
Bilingual aphasia and subcortical-cortical lesions. 147
Ultrasound findings of the optic nerve and its arterial venous system in multiple sclerosis patients with and without optic neuritis vs. healthy controls. 146
Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. 139
Acute encephalopathy and polyneuropathy after disulfiram intoxication. 132
Mielite recidivante:esordio clinico di neuromielite ottica? 132
Depressive symptoms and MRI changes in multiple sclerosis 131
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 129
Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. 122
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. 122
MMP-9 microsatellite polymorphism and multiple sclerosis. 118
Trigeminal neuralgia due to contralateral meningioma of the posterior cranial fossa. 117
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. 115
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. 115
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 114
Proton magnetic resonance spectroscopy during transient global amnesia 113
Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 112
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. A CASE-CONTROL STUDY. I. FREQUENCY AND COMPARISON OF GROUPS 107
A longitudinal study of brain atrophy and cognitive disturbances in early phase of relapsing-remitting multiple sclerosis 107
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 107
Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. 107
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. 105
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study 105
CORRELATION OF SEXUAL DYSFUNCTION AND BRAIN MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS 103
Headache induced by Chronic substance use:analysis of medication overused and minimum dose required to induce headache. 102
A longitudinal study of quality of life and side effects in patients with Multiple Sclerosis treated with Interferon beta-1a. 102
Efficacia del mesoglicano nella terapia della placca ateromasica dei vasi epiaortici 102
OLFACTORY LOSS IN MULTIPLE SCLEROSIS 101
HLA GENOTYPES AND DISEASE SEVERITY ASSESSED BY MAGNETIC RESONANCE IMAGING FINDINGS IN PATIENTS WITH MULTIPLE SCLEROSIS. 101
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. 99
Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. 97
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS 96
Acute akinesia, an unusual complication in Parkinson’s disease: a case report 96
Outcome of medication overuse headache after abrupt in-patient withdrawal. 94
Effect of intravenous methylprednisolone in the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 94
Prevalence of migraine in Croatia: a population-based survey. 93
Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. 93
Familial and environmental risk factors in Parkinson's disease: a case control study in North-East Italy. 93
Risk factors of multiple sclerosis:a case-control study. 92
Hyperglycemia at ischemic stroke onset as prognostic factor. 92
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. 90
Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. 90
Sexual dysfunction in multiple sclerosis. A MRI, neurophysiological and urodynamic study 89
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. 88
Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. 88
MRI TECHNIQUES AND COGNITIVE IMPAIRMENT IN EARLY PHASE OF RELAPSING-REMITTING MULTIPLE SCLEROSIS 87
Sclerosi multipla in overlap con sindrome di Sjogren 86
Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis. 84
Persistent aura without infarction:description of the first case studied with both brain SPECT and perfusion MRI. 82
Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. 82
Hypnic headache:rapid and long-lasting response to prednisone in two new cases. 80
Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis 76
Magnetic resonance imaging techniques as predictors of cognitive impairment in multiple sclerosis 71
Aritmie cardiache ed ischemia cerebrale acuta. Studio con monitoraggio Holter 70
Clinical surveillance of patients with multiple sclerosis 69
Incidence and prevalence of motor neuron disease in Coastal and Mountanious Regions, Croatia, 1984-1993. A preliminary survey. 69
Epstein-Barr Virus is Associated with Gray Matter Atrophy in Multiple Sclerosis 69
Approccio multidisciplinare alla Sclerosi Multipla. SPSM-RIabilitazione 66
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjectsJ 65
Central nervous system atrophy in Multiple Sclerosis: Introduction. 63
Beta 2-microglobulin level is not a marker of disease activity in Multiple Sclerosis. 62
Increased density in the middle cerebral artery by nonenhanced computed tomography. Prognostic value in acute cerebral infarction. 62
Atrial fibrillation and acute ischemic cerebrovascular disease. Study of 500 cases of cerebral infarction and transient cerebral ischemic attacks 62
Concordance of carotid bruit and positivity of computerized digital angiography of the epiaortic vessels in carotid stenotico-occlusive pathology 60
La rieducazione equestre: una possibilità riabilitativa 60
Fattori prognostici nell'emorragia cerebrale primitiva sopratentoriale 60
Trattamento con cicli di megadosi di metilprednisolone in pazienti affetti da sclerosi multipla cronico-progressiva: valutazione clinica a tre anni 60
Aspetti epidemiologici e clinici dello stroke. 59
L'aderenza alla terapia nella sclerosi multipla. Il punto di vista del medico 54
THE USE OF STANDARDIZED INCIDENCE AND PREVALENCE RATES IN EPIDEMIOLOGICAL STUDIES ON MULTIPLE SCLEROSIS. A META-ANALYSIS STUDY 53
Cysts of the atlantoaxial joint: excellent long-term outcome after posterolateral surgical decompression. Report of two cases. 53
Ematocrito, emoglobina, numero di globuli rossi e bianchi in rapporto al rischio di insorgenza delle vasculopatie cerebrali acute di tipo ischemico 52
Proton magnetic resonance spectroscopy study of ischemia in intracerebral hemorrhage 51
Le crisi ischemiche cerebrali transitorie e prolungate (TIA e RIND) 50
The latero-cervical murmur. Clinical and etiological observations on 515 cases belonging to a group of 2782 subjects examined 48
Side-effects and changes in systemic arterial pressure after administration of a single dose of lorazepam 48
Prevention and therapy of delirium tremens with tiapride 48
Fumo di sigaretta e rischio d'insorgenza delle vasculopatie cerebrali acute di tipo ischemico 48
Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis. A clinical and MRI study 47
Terapia antiossidante nell’ictus ischemico acuto 47
Disabilità e Qualità della Vita nelle persone colpite da Sclerosi Multipla 47
Update sul Teriflunomide 47
Case Report: Coexistence of SUNCT and Hypnic Headache in the Same Patient 47
Use of ticlopidine in patients with acute non-embolic cerebral infarcts 46
The blood level of uric acid as a risk factor in transient cerebral ischemic attacks and in non-embolic acute cerebral infarct 46
Nyctohemeral incidence of acute cerebral vasculopathies 46
Frontal parenchimal atrophy measures in multiple sclerosis. 45
Normalized regional brain atrophy measures in multiple sclerosis 45
Gaucher’s disease with Parkinson’s disease: Clinical and pathological aspects 45
Dyslipidemias and ischemic cerebral vasculopathies 43
SFAAT: Studio della fibrillazione atriale cronica non reumatica nell’area triestina. Risultati dell’arruolamento 43
Relationship between central nervous system atrophy and genetic-immunological markers in Multiple Sclerosis 42
Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednisolone: a possible prophylactic treatment. 42
Reliability of Doppler ultrasonography in relation to computerized digital angiography in patients with carotid bruit 42
The electroencephalogram and lacunar infarcts 42
Migraine crisis and neurological focal signs of slow or absent resolution (complicated migraine) 41
Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients 41
Familial nature of acute cerebral vasculopathies of the ischemic type 41
Totale 8.274
Categoria #
all - tutte 25.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.834 102 75 79 362 111 271 173 249 133 87 154 38
2020/20211.412 132 60 129 185 35 217 119 145 27 149 64 150
2021/2022852 28 95 12 92 4 32 31 58 143 106 100 151
2022/20231.175 136 68 130 142 117 255 29 89 153 3 43 10
2023/2024761 27 29 35 57 132 44 45 236 6 33 77 40
Totale 8.819